Published in Proc Natl Acad Sci U S A on October 13, 2008
Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics (2011) 2.53
The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Nat Genet (2012) 2.43
Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood. Malar J (2009) 2.08
Identification and genome-wide prediction of DNA binding specificities for the ApiAP2 family of regulators from the malaria parasite. PLoS Pathog (2010) 2.00
Plasmodium vivax: who cares? Malar J (2008) 1.98
The Apicomplexan AP2 family: integral factors regulating Plasmodium development. Mol Biochem Parasitol (2010) 1.74
Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes. Proc Natl Acad Sci U S A (2010) 1.74
Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samples. Malar J (2012) 1.48
Statistical estimation of cell-cycle progression and lineage commitment in Plasmodium falciparum reveals a homogeneous pattern of transcription in ex vivo culture. Proc Natl Acad Sci U S A (2009) 1.35
A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito. PLoS Negl Trop Dis (2010) 1.31
Histone deacetylases play a major role in the transcriptional regulation of the Plasmodium falciparum life cycle. PLoS Pathog (2010) 1.27
Quantitative time-course profiling of parasite and host cell proteins in the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics (2011) 1.17
Digital gene expression analysis of two life cycle stages of the human-infective parasite, Trypanosoma brucei gambiense reveals differentially expressed clusters of co-regulated genes. BMC Genomics (2010) 1.16
Plasmodium immunomics. Int J Parasitol (2010) 1.09
Consistent safety and infectivity in sporozoite challenge model of Plasmodium vivax in malaria-naive human volunteers. Am J Trop Med Hyg (2011) 1.09
Genomes of cryptic chimpanzee Plasmodium species reveal key evolutionary events leading to human malaria. Nat Commun (2016) 1.06
Variant surface antigens of malaria parasites: functional and evolutionary insights from comparative gene family classification and analysis. BMC Genomics (2013) 1.00
Characterization and gene expression analysis of the cir multi-gene family of Plasmodium chabaudi chabaudi (AS). BMC Genomics (2012) 0.99
Gene expression differences underlying genotype-by-genotype specificity in a host-parasite system. Proc Natl Acad Sci U S A (2014) 0.98
Development and evaluation of a prototype non-woven fabric filter for purification of malaria-infected blood. Malar J (2011) 0.98
Characterization and tissue-specific expression patterns of the Plasmodium chabaudi cir multigene family. Malar J (2011) 0.96
Genomic analysis of local variation and recent evolution in Plasmodium vivax. Nat Genet (2016) 0.94
Predicting and exploring network components involved in pathogenesis in the malaria parasite via novel subnetwork alignments. BMC Syst Biol (2015) 0.94
Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1). PLoS One (2011) 0.92
Genomics and integrated systems biology in Plasmodium falciparum: a path to malaria control and eradication. Parasite Immunol (2012) 0.90
Determination of the Plasmodium vivax schizont stage proteome. J Proteomics (2011) 0.90
Recent Progress in Functional Genomic Research in Plasmodium falciparum. Curr Genomics (2010) 0.90
Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays. Malar J (2011) 0.90
Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection. Am J Trop Med Hyg (2015) 0.89
The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax. Infect Immun (2013) 0.89
Rapid changes in transcription profiles of the Plasmodium yoelii yir multigene family in clonal populations: lack of epigenetic memory? PLoS One (2009) 0.88
PvRON2, a new Plasmodium vivax rhoptry neck antigen. Malar J (2011) 0.87
An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection. PLoS Negl Trop Dis (2016) 0.87
A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions. PLoS Negl Trop Dis (2015) 0.86
Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility. Antimicrob Agents Chemother (2015) 0.84
Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses. Am J Trop Med Hyg (2012) 0.84
Module-based subnetwork alignments reveal novel transcriptional regulators in malaria parasite Plasmodium falciparum. BMC Syst Biol (2012) 0.84
Identification of Immunodominant B-cell Epitope Regions of Reticulocyte Binding Proteins in Plasmodium vivax by Protein Microarray Based Immunoscreening. Korean J Parasitol (2015) 0.83
Genome comparison of human and non-human malaria parasites reveals species subset-specific genes potentially linked to human disease. PLoS Comput Biol (2011) 0.83
Immunoprofiling of the tryptophan-rich antigen family in Plasmodium vivax. Infect Immun (2015) 0.83
Genome cartography: charting the apicomplexan genome. Trends Parasitol (2011) 0.83
Cell biological characterization of the malaria vaccine candidate trophozoite exported protein 1. PLoS One (2012) 0.82
Core genome components and lineage specific expansions in malaria parasites plasmodium. BMC Genomics (2010) 0.82
New insights into the Plasmodium vivax transcriptome using RNA-Seq. Sci Rep (2016) 0.82
Clinical proteomics of the neglected human malarial parasite Plasmodium vivax. PLoS One (2011) 0.81
The case for a rational genome-based vaccine against malaria. Front Microbiol (2015) 0.81
Platform for Plasmodium vivax vaccine discovery and development. Mem Inst Oswaldo Cruz (2011) 0.81
Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria. Mol Cell Proteomics (2014) 0.81
Defining species specific genome differences in malaria parasites. BMC Genomics (2010) 0.80
Genetic diversity and selection in three Plasmodium vivax merozoite surface protein 7 (Pvmsp-7) genes in a Colombian population. PLoS One (2012) 0.80
Improving N-terminal protein annotation of Plasmodium species based on signal peptide prediction of orthologous proteins. Malar J (2012) 0.79
Exploring systems affected by the heat shock response in Plasmodium falciparum via protein association networks. Int J Comput Biol Drug Des (2014) 0.79
Plasmodium vivax trophozoite-stage proteomes. J Proteomics (2014) 0.79
Naturally-acquired cellular immune response against Plasmodium vivax merozoite surface protein-1 paralog antigen. Malar J (2015) 0.79
Gene Models, Expression Repertoire, and Immune Response of Plasmodium vivax Reticulocyte Binding Proteins. Infect Immun (2015) 0.79
Interaction of Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 with Band 3 on Human Erythrocyte Surface Facilitates Parasite Growth. J Biol Chem (2015) 0.79
Low genetic diversity in the locus encoding the Plasmodium vivax P41 protein in Colombia's parasite population. Malar J (2014) 0.79
Identification of Plasmodium vivax proteins with potential role in invasion using sequence redundancy reduction and profile hidden Markov models. PLoS One (2011) 0.78
Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1). Malar J (2011) 0.78
Characterizing PvARP, a novel Plasmodium vivax antigen. Malar J (2013) 0.77
Reality check for malaria proteomics. Genome Biol (2009) 0.77
Plasmodium vivax Tryptophan Rich Antigen PvTRAg36.6 Interacts with PvETRAMP and PvTRAg56.6 Interacts with PvMSP7 during Erythrocytic Stages of the Parasite. PLoS One (2016) 0.77
CD4+ T cell response correlates with naturally acquired antibodies against Plasmodium vivax tryptophan-rich antigens. Infect Immun (2015) 0.77
Identification of a reticulocyte-specific binding domain of Plasmodium vivax reticulocyte-binding protein 1 that is homologous to the PfRh4 erythrocyte-binding domain. Sci Rep (2016) 0.77
A novel subnetwork alignment approach predicts new components of the cell cycle regulatory apparatus in Plasmodium falciparum. BMC Bioinformatics (2013) 0.77
A large scale Plasmodium vivax- Saimiri boliviensis trophozoite-schizont transition proteome. PLoS One (2017) 0.76
Molecular cloning of Plasmodium vivax calcium-dependent protein kinase 4. Korean J Parasitol (2010) 0.76
Remarkable stability in patterns of blood-stage gene expression during episodes of non-lethal Plasmodium yoelii malaria. Malar J (2012) 0.76
Identification and characterization of the Plasmodium vivax thrombospondin-related apical merozoite protein. Malar J (2010) 0.76
Integrated analysis of the Plasmodium species transcriptome. EBioMedicine (2016) 0.76
Heterogeneous genetic diversity pattern in Plasmodium vivax genes encoding merozoite surface proteins (MSP) -7E, -7F and -7L. Malar J (2014) 0.76
Association of NMT2 with the acyl-CoA carrier ACBD6 protects the N-myristoyltransferase reaction from palmitoyl-CoA. J Lipid Res (2015) 0.76
Reticulocyte Preference and Stage Development of Plasmodium vivax Isolates. J Infect Dis (2016) 0.75
Plasmodium Helical Interspersed Subtelomeric (PHIST) Proteins, at the Center of Host Cell Remodeling. Microbiol Mol Biol Rev (2016) 0.75
Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia. Proc Natl Acad Sci U S A (2016) 0.75
Translational regulation in blood stages of the malaria parasite Plasmodium spp.: systems-wide studies pave the way. Wiley Interdiscip Rev RNA (2016) 0.75
Recognition of Human Erythrocyte Receptors by the Tryptophan-Rich Antigens of Monkey Malaria Parasite Plasmodium knowlesi. PLoS One (2015) 0.75
Antigenicity and immunogenicity of PvRALP1, a novel Plasmodium vivax rhoptry neck protein. Malar J (2015) 0.75
Comparative Genomics and Systems Biology of Malaria Parasites Plasmodium. Curr Bioinform (2012) 0.75
Evidence of functional divergence in MSP7 paralogous proteins: a molecular-evolutionary and phylogenetic analysis. BMC Evol Biol (2016) 0.75
The Plasmodium vivax rhoptry neck protein 5 is expressed in the apical pole of Plasmodium vivax VCG-1 strain schizonts and binds to human reticulocytes. Malar J (2015) 0.75
Identification of a novel merozoite surface antigen of Plasmodium vivax, PvMSA180. Malar J (2017) 0.75
Further evaluation of the NWF filter for the purification of Plasmodium vivax-infected erythrocytes. Malar J (2017) 0.75
Heavy path mining of protein-protein associations in the malaria parasite. Methods (2015) 0.75
Basigin interacts with Plasmodium vivax tryptophan-rich antigen PvTRAg38 as a second erythrocyte receptor to promote parasite growth. J Biol Chem (2016) 0.75
Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum. PLoS Negl Trop Dis (2017) 0.75
Characterization of P. vivax blood stage transcriptomes from field isolates reveals similarities among infections and complex gene isoforms. Sci Rep (2017) 0.75
Laser capture microdissection enables transcriptomic analysis of dividing and quiescent liver stages of Plasmodium relapsing species. Cell Microbiol (2017) 0.75
Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89
The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis (2004) 14.42
The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol (2003) 11.86
The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg (2001) 11.74
Discovery of gene function by expression profiling of the malaria parasite life cycle. Science (2003) 10.57
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med (2008) 6.61
Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature (2008) 5.96
Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum. Cell (2005) 4.33
Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites. Cell (2005) 4.26
Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature (2007) 3.69
Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote. BMC Genomics (2004) 3.68
Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites. Genome Biol (2006) 3.45
Discovery of the principal specific transcription factors of Apicomplexa and their implication for the evolution of the AP2-integrase DNA binding domains. Nucleic Acids Res (2005) 3.36
A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell (1992) 3.19
Specific DNA-binding by apicomplexan AP2 transcription factors. Proc Natl Acad Sci U S A (2008) 3.10
Mitotic induction and maintenance by overexpression of a G2-specific gene that encodes a potential protein kinase. Cell (1988) 2.88
Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains. Nucleic Acids Res (2006) 2.78
Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS One (2007) 2.66
Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites. Int J Parasitol (2004) 2.37
Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob Agents Chemother (2003) 2.26
Effect of plasmodial RESA protein on deformability of human red blood cells harboring Plasmodium falciparum. Proc Natl Acad Sci U S A (2007) 2.14
Preferential invasion of malarial merozoites into young red blood cells. Blood Cells (1990) 2.13
The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum. Genome Biol (2005) 1.91
Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. Gene (2008) 1.89
A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature (2001) 1.89
Parasitological review. Plasmodium: the fine structure of malarial parasites. Exp Parasitol (1971) 1.71
The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax. J Infect Dis (2004) 1.65
Epigenetic silencing of Plasmodium falciparum genes linked to erythrocyte invasion. PLoS Pathog (2007) 1.63
Caveola--vesicle complexes in the plasmalemma of erythrocytes infected by Plasmodium vivax and P cynomolgi. Unique structures related to Schüffner's dots. Am J Pathol (1975) 1.57
Plasmodium vivax trophozoites insensitive to chloroquine. Malar J (2008) 1.54
Progress in in silico functional genomics: the malaria Metabolic Pathways database. Trends Parasitol (2006) 1.54
The role of KAHRP domains in knob formation and cytoadherence of P falciparum-infected human erythrocytes. Blood (2006) 1.46
Selection of long oligonucleotides for gene expression microarrays using weighted rank-sum strategy. BMC Bioinformatics (2007) 1.45
Plasmodium falciparum ring-infected erythrocyte surface antigen is released from merozoite dense granules after erythrocyte invasion. Infect Immun (1991) 1.36
Acidification of the malaria parasite's digestive vacuole by a H+-ATPase and a H+-pyrophosphatase. J Biol Chem (2002) 1.28
Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients. Mol Biochem Parasitol (2006) 1.25
Variant proteins of Plasmodium vivax are not clonally expressed in natural infections. Mol Microbiol (2005) 1.23
Plasmodium falciparum: genome wide perturbations in transcript profiles among mixed stage cultures after chloroquine treatment. Exp Parasitol (2007) 1.21
Organization of ETRAMPs and EXP-1 at the parasite-host cell interface of malaria parasites. Mol Microbiol (2006) 1.20
PfPK7, an atypical MEK-related protein kinase, reflects the absence of classical three-component MAPK pathways in the human malaria parasite Plasmodium falciparum. Mol Microbiol (2005) 1.18
Variable expression of the 235 kDa rhoptry protein of Plasmodium yoelii mediate host cell adaptation and immune evasion. Mol Microbiol (2007) 1.14
Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax. Mol Biochem Parasitol (2005) 1.14
Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee. Am J Trop Med Hyg (1986) 1.11
Plasmodium falciparum merozoite surface protein 8 is a ring-stage membrane protein that localizes to the parasitophorous vacuole of infected erythrocytes. Infect Immun (2005) 1.10
Identification of basic transcriptional elements required for rif gene transcription. Int J Parasitol (2006) 0.97
Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
Typhoid fever. N Engl J Med (2002) 12.96
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet (2012) 11.82
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med (2004) 10.14
Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A (2004) 8.95
Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature (2002) 8.92
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (2010) 8.52
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med (2005) 8.36
How clonal is Staphylococcus aureus? J Bacteriol (2003) 7.97
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis (2012) 6.94
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol (2006) 6.34
Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol (2010) 6.28
A major genome region underlying artemisinin resistance in malaria. Science (2012) 6.25
PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res (2003) 6.19
Mixed-species malaria infections in humans. Trends Parasitol (2004) 6.01
A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science (2005) 5.99
Spiroindolones, a potent compound class for the treatment of malaria. Science (2010) 5.94
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis (2009) 5.90
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One (2009) 5.81
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J (2011) 5.65
The murine cerebral malaria phenomenon. Trends Parasitol (2009) 5.62
Macronuclear genome sequence of the ciliate Tetrahymena thermophila, a model eukaryote. PLoS Biol (2006) 5.44
Comparative genomics of trypanosomatid parasitic protozoa. Science (2005) 5.37
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg (2010) 5.10
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med (2005) 4.65
Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun (2002) 4.62
Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg (2007) 4.58
The pathophysiology of vivax malaria. Trends Parasitol (2009) 4.57
Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A (2010) 4.50
Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med (2005) 4.47
Manslaughter by fake artesunate in Asia--will Africa be next? PLoS Med (2006) 4.46
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
The Plasmodium genome database. Nature (2002) 4.36
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis (2007) 4.35
Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J (2008) 4.33
In vivo parasitological measures of artemisinin susceptibility. J Infect Dis (2010) 4.25
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J (2009) 4.25
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis (2006) 4.14
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet (2004) 4.14
Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc Natl Acad Sci U S A (2012) 4.10
Early origin and recent expansion of Plasmodium falciparum. Science (2003) 4.07
Counterfeit anti-infective drugs. Lancet Infect Dis (2006) 3.91
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet (2006) 3.90
Rickettsial infections and fever, Vientiane, Laos. Emerg Infect Dis (2006) 3.87
High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis (2010) 3.81
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet (2004) 3.72
A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. Mol Biol Evol (2003) 3.67
Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One (2013) 3.66
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis (2002) 3.46
Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites. Genome Biol (2006) 3.45
Scrub typhus serologic testing with the indirect immunofluorescence method as a diagnostic gold standard: a lack of consensus leads to a lot of confusion. Clin Infect Dis (2007) 3.23
Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis (2010) 3.21
The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med (2005) 3.15
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin Infect Dis (2005) 3.15
In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J (2012) 3.13
How much fat is necessary to optimize lumefantrine oral bioavailability? Trop Med Int Health (2007) 3.13
Artemisinin combination therapy for vivax malaria. Lancet Infect Dis (2010) 3.08
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis (2010) 3.08
The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis (2008) 3.05
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin Infect Dis (2009) 3.05
Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. Mol Biol Evol (2006) 3.01
How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health (2005) 2.95
Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol (2004) 2.92
On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis (2010) 2.91